| Literature DB >> 30275835 |
Agricola Joachim1, Sabrina J Moyo1,2, Lillian Nkinda1, Mtebe Majigo1, Sima Rugarabamu1, Elizabeth G Mkashabani1, Elia J Mmbaga3, Naboth Mbembati4, Said Aboud1, Eligius F Lyamuya1.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) among health care workers (HCWs) increases the risk of spreading the organism in hospital settings. A cross-sectional study was conducted between June and October 2016 among HCWs in tertiary and regional hospitals in Dar es Salaam, Tanzania, to determine the MRSA nasal carriage rate. Nasal swabs were collected from HCWs and cultured on mannitol salt agar. S. aureus was identified based on colonial morphology, Gram staining, catalase, coagulase, and DNase test results. MRSA was detected using the cefoxitin disk. Among 379 HCWs enrolled, 157/379 (41.4%) were colonized with S. aureus, of whom 59 (37.6%) were MRSA carriers giving an overall prevalence of 59/379 (15.6%). MRSA carriage was high among HCWs in Temeke (56.9%) and Amana (37.5%) regional hospitals. A high proportion of MRSA carriage was detected among nurses (35, 45.5%). MRSA isolates showed high resistance toward kanamycin (83.7%), gentamicin (83.1%), ciprofloxacin (71.2%), and trimethoprim-sulphamethoxazole (46.8%) compared to methicillin-sensitive S. aureus isolates (p ≤ 0.001). In conclusion, we found a high nasal carriage of MRSA and resistance to commonly prescribed antimicrobial agents among HCWs. Implementation of infection control measures including contact precautions, urgent reporting of MRSA laboratory results, and routine MRSA screening of HCWs is highly needed to reduce MRSA spreading.Entities:
Year: 2018 PMID: 30275835 PMCID: PMC6151361 DOI: 10.1155/2018/5058390
Source DB: PubMed Journal: Int J Microbiol
Demographic and clinical characteristics of study participants.
| Characteristic | Frequency | Percentage (%) |
|---|---|---|
|
| ||
| <45 | 325 | 85.8 |
| >45 | 54 | 14.2 |
|
| ||
| Male | 157 | 41.4 |
| Female | 222 | 58.6 |
|
| ||
| Amana | 102 | 26.9 |
| Temeke | 104 | 26.9 |
| MNH | 99 | 26.2 |
| ORCI | 74 | 19.5 |
|
| ||
| Medical wards | 203 | 53.6 |
| Surgical wards | 171 | 45.1 |
| ICU | 5 | 1.3 |
|
| ||
| Doctors | 182 | 48.0 |
| Nurses | 169 | 44.6 |
| Others | 28 | 7.4 |
|
| ||
| <5 years | 171 | 45.1 |
| >5 years | 208 | 54.9 |
|
| ||
| Yes | 185 | 48.7 |
| No | 194 | 51.3 |
|
| ||
| Yes | 42 | 11.1 |
| No | 337 | 88.8 |
|
| ||
| Frequently | 360 | 9.1 |
| Occasionally | 17 | 4.5 |
| No | 2 | 0.5 |
MNH, Muhimbili National Hospital; ORCI, Ocean Road Cancer Institute; ICU, intensive care unit; anesthesiologist and radiotherapist.
Characteristics of study participants by MRSA or MSSA carriage status.
| Characteristic | MRSA positive ( | MSSA ( |
|
|---|---|---|---|
|
| |||
| <45 | 51 (38.1) | 83 (61.9) | 0.76 |
| >45 | 8 (34.8) | 15 (65.2) | |
|
| |||
| Male | 20 (31.2) | 44 (68.8) | 0.17 |
| Female | 39 (41.9) | 54 (58.1) | |
|
| |||
| Amana | 18 (37.5) | 30 (62.5) | 0.001 |
| Temeke | 29 (56.9) | 22 (43.1) | |
| MNH | 10 (27.0) | 27 (73.0) | |
| ORCI | 2 (9.5%) | 19 (90.5) | |
|
| |||
| Medical wards | 28 (34.6) | 53 (65.4) | 0.40 |
| Surgical wards | 30 (40.5) | 44 (59.5) | |
| ICU | 1 (50) | 1 (50) | |
|
| |||
| Doctors | 21 (30.9) | 47 (69.1) | 0.13 |
| Nurses | 35 (45.5) | 42 (54.5) | |
| Others | 3 (25.0) | 9 (75.0) | |
|
| |||
| <5 years | 22 (31.4) | 48 (68.6) | 0.15 |
| >5 years | 37 (42.5) | 50 (57.5) | |
|
| |||
| Yes | 34 (42.5) | 46 (57.5) | 0.19 |
| No | 25 (32.5) | 52 (67.5) | |
|
| |||
| Yes | 4 (22.2) | 14 (77.8) | 0.15 |
| No | 55 (39.6) | 84 (60.4) | |
|
| |||
| Frequently | 59 (38.8) | 93 (61.2) | 0.16 |
| Occasionally | 0 (0) | 5 (100) | |
| No | 0 (0) | 0 (0) |
MNH, Muhimbili National Hospital; ORCI, Ocean Road Cancer Institute; ICU, intensive care unit; anesthesiologist and radiotherapist.
Resistance pattern among MRSA and MSSA isolates.
| Antimicrobial drug | MRSA ( | MSSA ( |
|
|---|---|---|---|
| Penicillin | NA | 88 (89.8) | |
| Trimethoprim-sulphamethoxazole | 22 (46.8) | 5 (9.6) | ≤0.001 |
| Ciprofloxacin | 42 (71.2) | 1 (1.0) | ≤0.001 |
| Gentamicin | 49 (83.1) | 4 (4.1) | ≤0.001 |
| Kanamycin | 41 (83.7) | 6 (6.4) | ≤0.001 |
| Clindamycin | 8 (13.8) | 6 (6.1) | 0.1 |
| Erythromycin | 46 (78.0) | 41 (41.8) | ≤0.001 |
| Linezolid | 0 (0) | 0 (0) | |
| Mupirocin | 6 (10.2) | 3 (3.1) | 0.06 |
Antimicrobial susceptibility testing was performed to only 98 S. aureus isolates. NA, not applicable. MRSA isolates are considered resistant to other beta-lactam agents including penicillin; hence, the testing was not done.
Prevalence of different antimicrobial resistance types among MRSA and MSSA isolates.
| Resistance type | Overall, | MRSA, | MSSA, |
|
|---|---|---|---|---|
| iMLSB | 51 (32.5) | 29 (49.2) | 22 (22.4) | ≤0.001 |
| cMLSB | 18 (11.5) | 6 (10.2) | 12 (12.2) | 0.7 |
| MS phenotype | 36 (22.9) | 14 (23.7) | 22 (22.4) | 0.8 |
| MDR | 61 (38.9) | 51 (86.4) | 10 (10.2) | ≤0.001 |
| Total | 157 | 59 | 98 |
iMLSB, inducible clindamycin resistance; cMLSB, constitutive clindamycin resistance; MS phenotype, resistance to erythromycin alone; MDR, multidrug resistance.
Association between MRSA nasal carriage and risk factors among HCWs.
| Characteristic | MRSA positive, | Univariate OR (95% CI); | Multivariate OR (95% CI); |
|---|---|---|---|
|
| |||
| <45 ( | 51 (15.7) | 1 | 1 |
| >45 ( | 8 (14.8) | 1.1 (0.47–2.40); 0.8 | 1.8 (0.4–4.4); 0.5 |
|
| |||
| Male ( | 20 (12.7) | 1 | 1 |
| Female ( | 39 (17.6) | 0.6 (0.38–1.22); 0.2 | 1.3 (0.57–2.8); 0.5 |
|
| |||
| Amana ( | 18 (17.6) | 7.7 (1.73–34.38); 0.007 | 10.3 (2.0–52.3); 0.005 |
| Temeke ( | 29 (27.9) | 13.9 (3.20–60.47); ≤0.001 | 20 (3.9–99.3); ≤0.001 |
| MNH ( | 10 (10.1) | 4.04 (0.85–19.05); 0.07 | 5.3 (1.0–27.9); 0.04 |
| ORCI ( | 2 (2.7) | 1 | 1 |
|
| |||
| Medical wards ( | 28 (13.8) | 1 | 1 |
| Surgical wards ( | 30 (17.5) | 0. 64 (0.69–5.93); 0.6 | 0.7 (0.37–1.32); 0.2 |
| ICU | 1 (20) | 0.85 (0.92–7.88); 0.8 | 1.7 (0.15–16.8); 0.7 |
|
| |||
| Doctors ( | 21 (11.5) | 1.08 (0.30–3.91); 0.8 | 0. 43 (0.1–1.87); 0.2 |
| Nurses ( | 35 (20.7) | 2.17 (0.62–7.63); 0.2 | 0. 84 (0.2–3.55); 0.8 |
| Others | 3 (10.7) | 1 | 1 |
|
| |||
| <5 years ( | 22 (12.9) | 1 | 1 |
| >5 years ( | 37 (17.8) | 0.68 (0.38–1.20); 0.2 | 2.08 (1.10–4.02); 0.03 |
|
| |||
| Yes ( | 34 (18.4) | 1.52 (0.86–2.66); 0.1 | 1.4 (0.76–2.58); 0.2 |
| No ( | 25 (12.9) | 1 | 1 |
|
| |||
| Yes ( | 4 (9.5) | 0.54 (0.18–1.57); 0.2 | 0. 35 (0.11–1.14); 0.08 |
| No ( | 55 (16.3) | 1 | 1 |
MNH, Muhimbili National Hospital; ORCI, Ocean Road Cancer Institute; ICU, intensive care unit; anesthesiologist and radiotherapist.